Denali Therapeutics to Give Opening Plenary Address at Alzheimer’s Association International Conference (AAIC) 2026 and Highlight Breakthroughs in Delivering Biologic Therapies Across Blood-Brain Ba

Go back to Denali Therapeutics to Give Opening Plenary Address at Alzheimer’s Association International Conference (AAIC) 2026 and Highlight Breakthroughs in Delivering Biologic Therapies Across Blood-Brain Ba
(NASDAQ: DNLI) Delayed: 23.64 -0.19 (0.8%)
Previous Close $23.83    52 Week High
Open $23.61    52 Week Low
Day High $24.05    P/E N/A 
Day Low $23.42    EPS
Volume 1,321,441